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ABSTRACT
The Effects of Exercise on Homocyteine Levels in Men and Women
by
Tracey Michelle Zuehlsdorff
Dr. Lawrence Golding, Examination Committee Chair 
Professor of Kinesiology 
University of Nevada, Las Vegas
A recent coronary risk factor,and one believed to be and important biochemical 
marker of Coronary Heart Disease, is elevated levels of serum homocysteine (Boushley 
et al., 1995; Malinow et al., 1994; Malinow et al., 1999; Nygard et al., 1995; Stampfer et 
al., 1992). Serum homocysteine levels above 10 umol/L are considered elevated. There 
are several unalterable factors, which result in the elevation of homocysteine such as 
heredity, age, and gender. There are other factors that are alterable such as diet and 
possibly exercise. The purpose of the study was to determine if a 12-week daily 
progressive exercise program reduced homocysteine levels in men and women. Six men 
and four women between the ages of 32 and 50 years of age participated in the study.
The subjects were all sedentary, business or professional individuals who joined the study 
to improve their physical fitness. Subjects’ homocysteine levels were 10 umol/L or 
greater. The female subjects were all premenopausal. Homocysteine levels were 
assessed before and after the 12-week exercise program and a dependent t test evaluated 
the changes (oc = .05). After the 12-week exercise program the analysis revealed a 
significant reduction in
111
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homocysteine levels (t = 5.71, p<.05) providing evidence that regular exercise reduces 
homocysteine levels in men and women.
IV
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CHAPTER 1 
INTRODUCTION
Cardiovascular disease is the major cause of death in the United States, and the 
American Heart Association has publicized the factors involved in the development of 
Coronary Heart Disease (CHD). These coronary risk factors include hypertension, 
elevated total cholesterol levels, cigarette smoking, sedentary living, obesity, 
uncontrolled diabetes, and others. One of the more recent factors, and one believed to be 
an important biochemical marker, of CHD is elevated levels of serum Homocysteine 
(Boushey et al., 1995; Malinow et al., 1994;Malinow et al., 1999; Nygard et al., 1995; 
Stampfer et al., 1992). Homocysteine (hcy) is derived from the metabolism of the amino 
acid methionine. Normal serum homocysteine levels are below 10 umol/L; borderline 
elevated homocysteine is between 10 and 15 umol/L; and elevated homocystiene is 
identified as 15 umol/1 or greater (Spectra Cell Lab). Elevated homocysteine is termed 
hyperhomocystienemia. Even though most laboratories consider homocysteine levels 
between 5 and 15 umol/L as the normal range, studies (Ségala et al., 2000) have shown 
that homocystiene levels above 6.3 umol/L result a progressive risk of coronary heart 
disease. Wilcken and colleagues in 1976 (Spectra Cell laboratories) first demonstrated a 
relationship between elevated homocystiene levels and cardiovascular disease. They 
showed that patients with premature atherosclerosis had elevated hcy levels in 
comparison to control subjects. Since 1976, several studies have shown high
1
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homocystiene levels with the increased incidence of heart disease (Boushey et al., 1995; 
Malinow et al., 1994; Nygard et al., 1995; Stampfer et al., 1992; Kang et al., 1986).
Blood homocystiene levels tend to increase with age (Nygard et al., 1995). However, 
hyperhomocysteinemia is observed in 30% of patients with known coronary artery 
disease and 42% of patients with cerebrovascular disease (Stein et al., 1998). The 
American Heart Association has reported that moderate and intermediate 
hyperhomocysteinemia is present in 47% of patients with coronary, cerebral, or 
peripheral arterial occlusive diseases (Malinow et al., 1999). The Physician’s Health 
Study (Stampfer et al., 1992) studied 14,916 apparently healthy male physicians for five 
years, of which 271 subsequently developed myocardial infarctions. The homocysteine 
levels were significantly higher in the physicians who suffered the myocardial 
infarctions. Malinow et al. (1989) followed 47 patients with peripheral arterial occlusive 
disease and in all cases plasma homocysteine was elevated. In another study Malinow et 
al. (1996) found elevated homocysteine levels in 40% of patients with coronary heart 
disease. There is considerable evidence to link elevated homocysteine levels and heart 
disease (Malinow et al., 1989; Malinow et al., 1996; Stampfer et al., 1992).
There are several factors resulting in elevated homocysteine levels: heredity, age, 
and gender. These factors are unalterable, however, some factors, such as diet, are 
alterable (Nygard et al., 1995; Malinow et al., 1996; Genest et al., 1991 ; William et al., 
1990; Malinow et al., 1999; Moustapha et al., 1999). Heredity is considered one of the 
greatest reasons for elevated homocystiene. Several studies (Malinow et al., 1996;
Genest et al., 1991; Williams et al., 1990) have linked heredity to elevated homocysteine 
levels. An autosomal recessive genetic disorder called Homocysteinuria effects 1:200,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
000 births. This condition is caused by inherited errors of metabolism and can cause 
skeletal abnormalities, mental retardation, and a high incidence of heart disease (Malinow 
et al., 1999). Age and gender are two other unalterable factors in elevated homocysteine 
levels, homocysteine levels tend to increase with age, and males tend to have higher 
homocysteine levels than females (Nygard et al., 1995). In females homocysteine levels 
tends to increase after menopause and decrease during pregnancy. However, 
postmenopausal women can control the increase in homocysteine by using estrogen 
replacement therapy (Nygard et al., 1995; Moustapha et al., 1999).
One important factor often resulting in elevated homocysteine levels is diet. Diet, 
and in particular the amount and kind of vitamins consumed, can be controlled and these 
tend to effect the homocysteine level. Consuming or supplementing the RDA for 
Vitamin B6, B12, and folic acid normally prevents elevated homocysteine levels. The 
RDA for folic acid is 400 ug/day, the RDA for B6 is 2.0 mg/day, and the RDA for BI2 is 
3.0 ug/day (Malinow et al., 1999). Due to poorer absorption in older adults, maintaining 
adequate vitamin intake is especially important. If the recommended amount of these 
vitamins is not being met by diet alone, then supplementation is recommended.
One of the most accepted coronary risk factors is elevated serum cholesterol 
levels. Several studies have shown that exercise lowers total cholesterol levels and 
increases HDL cholesterol, which decreases the risk for cardiovascular disease (Gordon 
et al., 1994; Lennon et al., 1983; Grouse et al., 1997; Hubinger et al., 1992). Lennon and 
associates (1983) showed that 40 minutes of exercise increases HDL cholesterol, 
decreases total and LDL cholesterol. Hubinger and colleagues (1992) demonstrated that 
30 minutes of moderate exercise made a significant increase in HDL cholesterol. Gordon
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et al. (1994) demonstrated the importance of the intensity of exercise: a moderately 
trained male working at 75% of V02 max increased HDL cholesterol levels significantly. 
It was suggested that those with higher baseline levels of HDL cholesterol might require 
longer duration exercise to achieve the same affect. Crouse and colleagues (1997) 
demonstrated that a single bout of exercise had a significant affect on lipid concentration 
in hypercholesterolemic men: it increased HDL cholesterol and decreased total 
cholesterol and with continued training there was a significant decrease in LDL 
cholesterol.
The evidence indicating that exercise reduces total cholesterol suggests that 
exercise may also beneficially affect homocysteine levels. Since elevated homocysteine 
levels are an important risk factor for cardiovascular disease, the effects of exercise on 
homocysteine levels needs to be investigated. Nygard et al. (1995) demonstrated a linear 
relationship between total homocysteine levels and total and LDL cholesterol levels. 
Therefore, it could be hypothesized that when high LDL cholesterol levels persist, high 
homocysteine levels may be expected. Since exercise has been shown to lower 
cholesterol, it is also possible that exercise may lower elevated homocysteine levels.
To date, only two studies have examined the effect of exercise on homocysteine 
levels. The Norwegian Hordaland Homocysteine Study (Nygard et al., 1995) studied 
8,585 women and 7,591 men, between the ages 40 to 67 years. The purpose of this study 
was to investigate the relationship between homocysteine levels and other cardiovascular 
risk factors. The investigators determined that homocysteine levels were inversely 
related to physical activity. The men that participated in exercise had an average of a 
1.08 umol/L lower total homocysteine levels than their sedentary counterparts and the
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women had an average of a .65 umol/L lower level than sedentary subjects. However, in 
another study, Wright et al. (1998) found that the one bout of acute exercise had no affect 
on homocysteine levels. In their study 20 healthy young males ran on a treadmill at 70% 
of their max heart rate for 30 minutes.
Statement of the Problem 
The purpose of the present study was to investigate the effects of a 12-week daily 
exercise program on homocysteine levels in men and women aged 32 to 50 years. The 
hypothesis was that regular, progressive exercise significantly lowers elevated 
homocysteine levels. The research question was: Does persistent regular exercise reduce 
homocysteine levels?
Need for the Study
Since homocysteine has been determined to be an important biochemical marker 
of coronary heart disease, it was desirable to know if regular, daily exercise positively 
effects homocysteine levels.
Limitations and Assumptions
Limitations:
1. The financial laboratory cost of determining homocysteine levels and the limited age 
range of the subjects, limited the number of subjects. Since females needed to be 
premenopausal, women over 50 years of age were not used.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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2. A 12-week exercise program was used. A longer program of exercise may produce 
different results.
3. Some dietary information was obtained from the subjects, but it was not possible to 
rigorously control diet or supplementation use even though they were asked not to 
change or modify their diets and not to begin any diet supplementation during the 
study.
4. Since heredity is an unalterable factor involved in elevated homocysteine, it was not 
possible to know the level homocysteine due to heredity.
5. Although women were screened for menopausal status, it was not possible to be 
completely assured that all the women involved were premenopausal.
6. Study was limited to those that had serum homocysteine levels of 10 umol/L or 
greater.
Assumptions:
1. Subjects were asked to attend at least 3 of the 5 days of exercise each week. 
Attendance was taken, and it was assumed that individuals worked diligently while in 
the exercise sessions.
2. Subjects were asked to not change their diets and not begin taking any supplements.
It was assumed that they followed those requests
3. Subjects were asked if they were sedentary before the study. All reported that they 
were sedentary. Therefore it was assumed that they were sedentary previous to 
beginning the exercise program.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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4. Subjects all reported and signed consent forms that indicated that they were free of 
any heart disease or other major health complications.
5. It was assumed that all women that participated were premenopausal at the time of 
the study.
6. It was assumed that the Homocysteine levels were accurately assessed.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 2
LITERATURE REVIEW 
Medical Discovery
The interest in homocysteine started in 1933 when an eight-year-old boy was 
admitted to the Massachusetts General Hospital with symptoms of headaches, 
drowsiness, and vomiting, he also had signs of mental retardation and the lenses of both 
eyes were detached. The boy had indications of a stroke and died a few days later. The 
cause of death was recorded as arteriosclerosis of the carotid artery with a cerebral 
infarct, even though this was usually a condition reserved for older adults (McCully,
1997). This case was basically ignored for thirty-two years, and then in 1965, a young 
girl was evaluated at the same hospital for retarded mental development and had similar 
symptoms of the boy thirty -two years previous. The eight-year-old boy that had died 32 
years earlier was the young girl’s uncle (McCully, 1997). This was later determined to be 
a result of elevated homocysteine levels. In 1962 in Belfast, Ireland doctors studying the 
composition of urine in mentally retarded individuals found elevated homocysteine levels 
and the term homocysturinia was used (McCully, 1997). Homocysteine was analyzed in 
the urine as an amino acid formed from the normal breakdown of the proteins. The 
symptoms of the young girl and boy mentioned above were similar to those discovered in 
homocysturinia. The young girl was tested for elevated homocysteine, and was 
diagnosed with homocysturinia. After elevated homocystiene and homocystinuria
8
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became more diagnosable, research in the United States on elevated homocysteine began 
being published (McCully, 1997).
Metabolism
Homocysteine (hcy) is an amino acid formed from methionine. Excess 
methionine in the diet is converted to homocysteine. The RDA for methionine is .9 
g/day; however, the average American diet usually contains approximately 2 g/day of 
methionine (Stein et al., 1998). Methionine is found in all proteins and animal foods such 
as meat, eggs, milk, and cheese which contain more protein than most foods of plant 
origin. The RDA for protein based on weight is approxiamately 60 grams for adult men 
and 50 grams for adult women (McCully, 1997). The metabolism of homocysteine starts 
when methionine is introduced into the digestive tract. Methionine combines with an 
ATP molecule and forms S-adenosylmethionine (SAM), an intermediate, which then 
gives up a methyl group and becomes homocysteine. Homocysteine can then either be 
further metabolized by the transulfuration pathway to cystathionine and cysteine with the 
excretion of sulfur in the urine or it is remethylated by one of two pathways back into 
methionine (Carmel R & Jacobsen D, 2001).
In transsulfuration, homocyteine, in the presence of vitamin B6 and the enzyme 
cystathionine B-synthase combines with serine to form cystathionine from which 
cysteine, a-ketobutyrate, and ammonium are formed. This process produces the secretion 
of sulfur in the urine. Homocysteine can then be remethylated back into methionine by 
one of two pathways. One of the two pathways requires Vitamin B12 and allows 
homocysteine to pick up a methyl group from methyltetrahydrofolate, a folic acid
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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derivative, catalyzed by homocysteine methyltransferase (FHMT), forming methionine. 
The remaining tetrahydrofolate to then form 5, 10 methylene-tetrahydrofolate and 
continues through the metabolic pathway. In the other remethylation pathway, betaine 
donates a methyl group to homocysteine and forms methionine, and dimethylglycine. The 
two metabolic pathways tend to compete for the available homocysteine. Figure 1 on the 
next page illustrates the process.
Studies have demonstrated that in young adult men fed a diet adequate in 
methionine (14mmol/day), about 38% of homocysteine is remethylated to methionine 
and 62% is catabolized by transsulfuration (Shils et al., 1999). Elevations in 
homocysteine levels occur primarily through a genetic deficiency of cystathionine B 
synthase (CBS). With a deficiency in CBS, the transulfuration pathway for homocysteine 
metabolism is not possible. Other possible causes of elevated homocysteine levels occur 
with deficiencies in Vitamins B6, B12, and folic acid. Without these vitamins, the 
transulfuration and transmethylation pathways are not effective. Therefore, homocystiene 
cannot be excreted nor can it be reformed back into methionine. Although, these are the 
most common causes of elevated homocysteine levels, any error that does not allow 
homocystiene to either by excreted or remethylated into methionine has the potential to 
cause elevated homocystiene levels.
Total plasma homocysteine is the sum of all free homocysteine and protein-bound 
homocysteine. According to Spectra Cell Laboratories, mean value for normal total 
homocysteine is 10 umol/L and generally 10% higher in men than women and increases 
with age. Some research (Malinow et al., 1999) has indicated in the fasting patient, 
normal levels of plasma homocysteine are between 5 and 15 umol/L. However, according
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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to McCully (1997) if blood homocysteine levels can be kept below 10 umol/L a 
significant measure of protection against development and progression of arteriosclerosis 
is assured. Even though some laboratories find homocysteine levels between 5 and 15 
umol/L to be in a normal range, studies (Segala, 2001) have shown that homocysteine 
levels above 6.3 umol/L cause a steep and progressive risk of heart attack.
Methionine
ATP
THF ,X \
N 5,10 Methylene-THF Methyl-cobalamin
t
 ^  Dimethyl-glycine T 1J
f  SAM ^
B12, Folate
N5 Methyl-THF
Serine
Betaine
Choline
R
>R-CH3
S-Adensosine-hcy
Homocysteine
I  Requiring B6
©Cystathionine
i
Cysteine + ketobutyrate + NH4
Figure 1 : Methionine Metabolism
1. Methionine combines with ATP and forms S-adenosylmethionine (SAM), which 
forms Homocysteine.
2. Transulfuration pathway of homocysteine requiring Vitamin B6.
3. One remethylation pathway requiring Vitamin B12 and folate.
4. The second remethylation pathway requires betaine as a methyl donor to form 
methionine.
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Homocystinuria is a genetic disease that affects the metabolism of homocysteine. 
This is a rare autosomal recessive genetic disorder that approximately affects 1:200,000 
births (Malinow et al., 1999). Homocystinuria results from severe 
hyperhomocysteinemia caused by abnormaility of the metabolism of homocysteine.
There are three possible mechanisms for the abnormality of hcy metabolism; the first and 
most common cause is a lack of cystathionine B-synthase activity that can cause plasma 
homocysteine levels as high as 200 umol/L in untreated patients (Shils et al., 1999). The 
second common cause is a lack of N-methylenetetrahyrofblate reductance activity, which 
affects folate metabolism. The third possible cause of homocystinuria is an error in the 
synthesis of methylocobalamin (Shils et al., 1999). Overall, those with homocystinuria 
have a high incidence of vascular pathology that can lead to myocardial infarction, 
stroke, or pulmonary embolism (Malinow et al, 1999). Homocystinuria that is caused by 
a cystathionine B synthase deficiency can lead to dislocation of optic lenses, skeletal 
abnormalities, mental retardation, and neurological disorders (Shils et al, 1999). 
Fortunately, newborn screening for homocystinuria detects a CBS deficiency by primary 
screening for hypermethioninemia and secondary screening for elevated urine and/or 
plasma homocysteine levels (Shils et al, 1999).
Homocysteine and Heart Disease 
Elevated homocysteine level is presently an important biochemical marker for 
coronary heart disease. Several studies have shown a positive correlation between 
elevated hcy levels and the incidence of coronary heart disease (CHD). In 1992 Stampfer 
and his colleagues did one of the first prospective studies on homocysteine and CHD and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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was entitled The Physicians Health Study. These researchers followed 14, 916 male 
physicians between the ages of 40 and 84 years of age who, prior to the study, had not 
had any known myocardial infarctions or strokes. The homocysteine levels of the 
physicians were analyzed, compared and matched to their controls for five years. Two 
hundred seventy one of the physicians developed a myocardial infarction, and these had 
elevated homocysteine levels above 11 umol/L. Thirty one of the cases had 
homocysteine levels greater than 15.8 umol/L, which was found to be significant. This 
proportion would probably be higher in the general population, which is presumably less 
well nourished than US physicians. Selub and others (1995) showed a significant 
relationship between Carotid Artery Stenosis and elevated total homocysteine levels and 
low concentrations of folate and vitamin B6. They studied 1,041 men and women 
between the ages of 67 and 97 years from the Framingham Heart Study, which was a 
study done with a group of patients from Framingham, Massachusetts with coronary 
heart disease. The relationship between the maximal degree of stenosis of the extracranial 
carotid arteries and plasma homocysteine along with concentrations and intakes of folate. 
Vitamin B6, and B12 were examined. The study showed that high plasma homocysteine 
concentrations and low concentrations of folate and Vitamin B6 were associated with an 
increased risk of extracranial carotid-artery stenosis in the subjects.
Although the precise mechanisms by which elevated homocysteine can causes 
vascular damage is not completely understood, it is hypothesized that endothelial injury 
is a probable factor (Berwanger et al., 1995). It is speculated by researchers (McCully, 
1997; Malinow et al., 1993; Graham et al., 1997) that elevated homocysteine levels cause 
endothial dysfunction and aggregation of platlets by promoting oxidation at the cellular
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level. This oxidation process increases LDL accumulation and enhances foam cell 
formation which leads to the progression of occlusive arterial diseases. Studies have also 
correlated elevated homocystiene levels with peripheral arterial occlusive disease 
(PAOD) (Boers et al., 1985; Clarke et a., 1991; Malinow et al., 1989). Malinow et al. 
(1989) studied 47 patients with PAOD, 35 cases had carotid arterial involvement and 32 
subjects also had ileo femoral lesions, therefore, occlusion was found in both arterial 
areas in the about 80 % of the subjects. The results of the study showed that plasma 
homocysteine levels were elevated in the patients with PAOD when compared to their 
controls. Malinow et al., (1993) showed a correlation of elevated homocysteine to 
carotid arterial wall intimal-medial thickness in 287 case-controlled pairs of individuals 
free of clinical athersclerosis. Subjects for the study were selected from a sample of 
15,800 men and women between the ages of 45 and 64 years of age. The study revealed 
that the subjects with thickened carotid wall or occlusive arterial disease are more likely 
to have elevated homocysteine levels that their controls. Elevated homocystiene levels 
have also been noted in patients with cerebrovascular disease (Boers et al., 1985; 
Brattstrom et al., 1990; Clarke et al., 1991; Malinow et al., 1996). Brattstrom et al. 
(1992) matched 142 stroke survivors with 66 control subjects that were free of 
cerebrovascular disease. They found hyperhomocysteinemia present in 40% of stroke 
patients and only 6% of control subjects.
Vitamin Deficiency and Supplementation 
Besides genetic factors, vitamin deficiency is the most common cause of elevated 
homocysteine levels. Inadequate plasma concentrations of vitamin B6, B12, and/or folate
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contribute to 67% of cases of hyperhomocysteinemia (Spectra Cell Lab). The RDA for 
vitamin B6 is 2.0 mg/day and foods include fortified cereals, noncitrus fruits, poultry, 
beef, and vegetables such as artichokes, beans, cabbage, and asparagus. The RDA for 
vitamin B12 is 3.0 mcg/day and food sources include beef, poultry, and fortified cereals. 
Lastly, the RDA for folic acid is 400 meg and foods containing folic acid include fortified 
cereals, leafy green vegetables, fruits, and legumes (Malinow et al., 1999). However, the 
majority of the population does not meet the RDA requirements for these vitamins, and in 
addition, due to reduced absorption with age, this is most prominent in those over the age 
of 50 (Malinow et al., 1999). Therefore, supplementation of these three vitamins is 
recommended. Both folate and vitamin B12 are cofactors for methionine synthase and 
are needed to remove homocysteine.
In Vitamin B6, B12 and folate deficiency homocysteine is not metabolized and its 
concentration in the blood rises (Pancharuniti et al., 1994). Of the three vitamins 
involved in homocysteine metabolism, supplementation with folate seems to be the most 
successful in lowering high homocysteine levels (Franklin et al., 1998). Stein et al.
(1998) have shown that folic acid supplementation of 400 meg or more a day can 
decrease total Hcy levels up to 42%. However, supplementation with a combination of 
all three vitamins (Vitamin B6, B12, and Folate) results in a 72% reduction in total 
homocysteine. The American Heart Association recommends a folic acid dose between 
.2 and 15 mg/day to lower hcy levels. In addition, the AHA showed that the daily intake 
of fortified cereals, which contain 499 to 650 ug of folic acid per serving, and the RDA of 
the vitamin B6 and B12, can reduce homocysteine by 14%. However, there is a small 
danger with folic acid supplementation. A high folate intake may mask the development
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
16
of megaloblastic anemia characteristics of older patients with vitamin B12 deficiency 
(Moustapha et al., 1999). Therefore, it is important to screen older adults for vitamin 
B12 deficiency before beginning treatment for elevated hcy. Research (Boushley et al., 
1995) has demonstrated that large doses o f folic acid (5000 ug) are not necessary to 
reduce hyperhomocysteinemia. A folic acid dose of 650 ug reduced homocysteine 
concentrations by 42% in subjects. Boushley and others showed that there was no 
additional lowering of hcy after six weeks of treatment with 1000 meg folic acid per day,
0.4 mg/day of B12, and 12.2 mg/day of B6 when twice these amounts were given. This 
suggests that there may be an upper limit in supplementation as it relates to homocysteine 
reduction.
Although, folic acid is very effective in reducing homocysteine, combination 
therapy with vitamin B6 and B12 is suggested (Boushley et al., 1995). Cobalamin (B12) 
supplementation alone is only successful in reducing total homocysteine levels in cases of 
overt B12 deficiency (Boushley et al., 1995). Boushley and associates (1995) showed 
that pyridoxine (B6) is not effective in reducing elevated fasting total homocysteine 
levels when used alone. A few other vitamins that may affect homocysteine levels 
include riboflavin and nicotinic acid. Riboflavin can function as a cofactor for 
methylenetetrahydrofolate reductace (MTHFR), which is the enzyme that regulates the 
metabolic pathway for homocysteine. A .6 mg/day food intake of riboflavin can slightly 
reduce total homocysteine. On the other hand supplementations of 3000 + mg/day of 
nicotinic acid may elevate homocysteine levels. Research reported by the American 
Heart Association, (Malinow et al., 1999) has shown that users of multivitamin 
supplements have lower homocysteine levels that nonusers. McKay et al. (2000)
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reported lower homocysteine levels and improved vitamin B status with 
multivitamin/mineral supplementation. The study involved 80 men and women between 
50 and 87 years o f age with homocysteine levels of > 8 umol/L. Each subject received a 
multivitamin/mineral supplement or a placebo for 56 days while consuming their normal 
diets. The results showed plasma folate, pyridoxal phosphate, and vitamin B-12 
concentrations were increased 41.6, 36.5, and 13.8 %, respectively and no changes were 
observed in the placebo group. Mean homocysteine concentrations decreased 9.6% in the 
supplementation group, as well.
Heredity
Several studies have studied the heritability of plasma homocysteine in families. 
Malinow et al. (1996) reported various studies (Genest et al., 1991; Reed et al., 1991; 
Berg et al., 1992) that have shown hyperhomocysteinemia can be an inherited 
abnormality and possibly explains cases of early familial coronary artery disease. Genest 
and colleagues (1991) studied families of patients with premature CAD (coronary artery 
disease) to determine whether the hyperhomocysteinemia was familial. Subjects 
consisted of 176 men less than 60 years of age that had been diagnosed with CAD. Two 
hundred and fifty-five control subjects were also examined. The families of 71 of the 
subjects were also examined. Family included spouses and first generation relatives, 
resulting in a total of 370 subjects. The results showed that 20 families had elevated hey 
levels compared to controls and that 14% of the CAD patients did have familial 
hyperhomocysteinemia. Therefore, elevated homocysteine levels are partially genetically 
determined in individuals with CAD. Williams et al. (1990) measured homocysteine
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levels in 37 men and women with CAD and in 30 male and 18 female control participants 
who were matched for age and sex. Participants of the study were selected to include 13 
male sibling pairs with CAD, 13 male sibling pairs as control subjects and 13 spouse 
pairs as control subjects. The results showed significantly higher hey levels in CAD 
patients, among 26 male sibling pairs, a strong familial correlation of homocysteine was 
observed. The above studies suggest that hyperhomocysteinemia was and inherited 
abnormality and may explain certain cases of early familial CAD (Malinow et al., 1996).
Age
Advancing age is a contributing factor in elevated homocystiene levels. There is 
a high correlation between homocysteine and age indicating that total homocysteine 
levels increase in older individuals with or with out cardiovascular disease. Nygard and 
others (1995) revealed higher total homocysteine levels in men and women as their age 
increased. Their study examined 7,591 Norwegian men and 8,585 Norwegian women 
between the ages of 40 and 67 years. There are several causes for increasing hey levels 
with age. The production of Cystathionine B synthase and other enzymes involved in 
homocysteine metabolism tend to decline with age (Moustapha et al., 1999). Due to a 
decrease in the absorption of folate, vitamin B12 and B6 with age, an increase in 
homcysteine can occur (Moustapha et al., 1999). The amount of food consumed also 
tends to decline with age, which causes a decline in the dietary intake of Vitamin B6, 
B12, and folic acid. One study (vonEckardstein et al., 1999) found that elevated 
homocystiene levels are_significantly correlated with age, among other factors such as 
fibrinogen and plasma viscosity in CAD patients. Overall, age is an unalterable factor.
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which, can lead to elevated homocysteine levels. Therefore it is advisable to become 
aware of the alterable factors such as diet.
Gender and Menopause 
Nygard et al. (1995) indicated that because of a larger muscle mass and creatine 
synthesis, men tend to have higher homocysteine levels than women. In females, 
premenopausal women have lower homocysteine levels than postmenopausal women. 
However, postmenopausal women on estrogen replacement therapy tend not to have 
elevated homocysteine levels (Nygard et al., 1995; Malinow et al., 1994). This finding 
suggests that premenopausal women remethylate homocysteine to methionine better or 
that their transulfuration rate or renal excretion differs from postmenopausal women 
(Carmel, Jacobsen, 2001). Nygard et al. (1995) also indicated that increased levels of 
plasma estrogens may account for lower hey levels in pregnant women. However, 
Henderson (2000) showed no correlation between estrogen and homocysteine. He 
measured homocysteine levels before and after six months of estrogen replacement 
therapy and found no significant changes in homocysteine levels.
Homocysteine and Cholesterol 
Elevation in plasma homocysteine levels are found with increased levels of 
cholesterol and triglycerides (Karmin et al., 1998; Glueck et al., 1995). Nygard and 
associates (1995) found a positive correlation between total homocysteine and total 
cholesterol and LDL cholesterol when examining the relationship between cardiovascular 
risk factors and total homocysteine in plasma. According to Karmin et al. (1998)
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homocysteine stimulates the production and secretion of cholesterol in hepatic cells. In 
his study, hepatic cells were incubated with 4mM of homocysteine. This amount (4mM) 
is considerably higher than that found in the plasma of homocysteinemic patients because 
the chronic process of homocysteine in patients cannot be readily produced when using a 
cell culture model The results showed that homocysteine produced an elevated 
cholesterol level in the hepatic cell and stimulated the secretion of cholesterol by the 
cells. Glueck and others (1995) studied 482 patients with hyperlipidemia. Homocysteine 
levels were measured in all subjects and 18 of the 482 patients had elevated 
homocysteine levels (> 16.2 umol/L). However, of the 18 with elevated homocysteine,
13 had atherosclerotic vascular disease. Zulli and others (1998) found a positive effect 
among cholesterol, homocystiene, and triglyceride levels. The study used rats and fed 
them a control diet which consisted of a high cholesterol supplemented diet, a high 
methionine supplemented diet, and a combination of the two, a high cholesterol plus a 
high methionine supplemented diet. The results of the study showed that excess 
methionine and cholesterol feeding act positively to increase plasma homocysteine, 
cholesterol, and triglyceride levels. The methionine only diet showed an increase in 
homocysteine and the cholesterol only diet showed an increase in homocysteine, but the 
combined diet had the greatest effect and showed the greatest increase in homocysteine. 
Zulli and associates believed that humans show the same effect, therefore indicating that 
elevated levels of cholesterol increase homocystiene levels.
Elevated HDL cholesterol levels have been known to reduce overall risk of 
coronary heart disease. In contrast to the above studies Superko et al. (1997), reports that 
despite the protective effects that elevated HDL cholesterol has, athersclerosis can still
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occur in the setting of hyperhomocysteinemia. In his study, he reported an 82 year old 
women with elevated HDL cholesterol and normal LDL cholesterol levels with coronary 
artery disease. However, the patient did have elevated homocysteine levels. Therefore, 
there is a conflict in the research. However, Superko’s study only looked at one subject.
Homocystiene and Ethnicity 
There is not total agreement on the effect of ethnicity and elevated hey levels. 
Gerhard et al. (1999) concluded that premenopausal black women tend to have two to 
three times the incidence of CHD than similar white women. In addition, black women 
had higher levels of homocysteine levels than white premenopausal women. The study 
was conducted using 89 black women and 90 white women between the ages of 18 and 
45. The result showed that total homocysteine levels were significantly higher and 
plasma folate levels were significantly lower in the black women compared to their white 
counterparts. In contrast, Giles et al. (1999) concluded that there is no difference in 
homocysteme levels among different ethnic groups. The study examined data from the 
Third National Health and Nutrition Examination Survey. This was a survey that was 
used to examine the relationship between total homocysteine levels in 3,173 patients with 
acute myocardial infartions among whites, hlacks, and Mexican Americans over 40 years 
of age. The study revealed that there is an increase in the likelihood of myocardial 
infarction among those with elevated homocysteine levels (>15 umol/L), but 
homocysteine levels did not differ among blacks, whites, and Mexican Americans. Due 
to the inconsistent results of the two studies, further research is needed to determine the 
relationship between homocysteine levels and ethnicity.
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Diabetes and Kidney Disease 
Diabetes mellitus has been associated with heart disease (McCully, 1997; Bostom 
et al., 1994; Chauveau et al., 1993; Freidman et al., 1995). Diabetics often suffer from 
heart attack, stroke, kidney failure, blindness, and gangrene. A few of these ailments are 
a result of atherosclerosis. An adverse effect of kidney failure, whether it is from 
diabetes or other causes, is a large build up of homocysteine in the blood. The levels of 
homocysteine can become extremely high, sometimes reaching two to three times the 
normal values (McCully, 1997). According to Bostom et al. (1994), who examined a 
group of 24 patients between the ages of 35 and 70 years with End-Stage Renal Disease 
(ESRD) on maintenance dialysis. Subjects were matched with controls. Plasma 
homocysteine levels were higher in ESRD patients than in controls. Vitamin B 
concentrations were also examined in the above patients and elevated homocysteine 
levels were also apparent in the ESRD patients with normal and above normal vitamin B 
levels, suggesting that vitamin status in an independent factor. Chauveau et al. (1993) 
examined 118 adults with end stage renal disease (ESRD), 79 of the patients were not on 
dialysis and 39 patients were on maintenance dialysis. All subjects were matched for 
controls. The 79 nondialyzed patients did not receive any vitamin supplementation and 
had homocysteine levels two to four times greater than their controls. Of the 39 patients 
on maintenance dialysis all received adequate levels of Vitamin B12 and folate and still 
had elevated postdialysis homocysteine levels. Overall, the study showed that as renal 
function decreased, homocysteine levels increased. Therefore there is evidence that 
patients with renal failure have high homocysteine levels. Individuals receiving dialysis 
treatment, either hemodialysis or continuous peritoneal dialysis still may show elevated
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hey levels, although homocysteine levels tend to be even more elevated in imtreated 
patients (Freidman et al., 1995). The above research also indicates that vitamin therapy 
does not decrease those levels of homocysteine in patients with renal disease.
Homocysteine and Alzheimer’s Disease 
Alzheimer’s disease and dementia has been related to athersclerosis and vascular 
disease (Perry et al., 1999; Bell et al., 1992; Clarke et al., 1998; McCadden et al., 1998). 
The relationship between the two began in the late 1980’s with The Oxford Project to 
Investigate Memory and Aging (OPTIMA). OPTIMA is an ongoing study that was 
established in 1988 to study Alzheimer’s disease and all factors that affect it. The 
projects found research to link elevated levels of homocysteine causing damage to the 
blood vessels in the brain resulting in the development of Alzheimer’s disease (Perry, 
1999). McCaddon et al. (1998) studied 30 subjects 65 years or older with Alzheimer’s 
disease and found a significant relationship between homocysteine levels and scores of 
the Cambridge Cognitive Examination (CAMCOG), which is the cognitive assessment 
for elderly individuals with mental disorders. The test assesses retention skills and short­
term memory skills. Clarke et al. (1998) found a significant relationship between 
homocysteine levels and scores on the Cambridge Cognitive Exam and a Mini-Mental 
State Exam (MMSE). The MMSE assesses a combination of orientation skills, ability to 
follow directions, and attention skills. Homocysteine levels, serum folate and vitamin 
B12 levels were also examined. The study showed lower levels of vitamin B12 and 
folate in the Alzheimer’s patients with elevated homocysteine levels. The study by 
Clarke et al. (1998) also suggests that adequate amounts of folate and B12 may reduce
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the risk of Alzheimer’s disease. Research has fovmd that Alzheimer’s patients as well as 
those with dementia tend to have lower levels of the two vitamins than those with normal 
brain function (Tufts University Health & Nutrition Letter, 1999). Higher levels of 
homocysteine have been shown to reduce the ability to learn and remember, especially 
with the association of low levels of folate and Vitamin B12 (Miller et al., 1999). Riggs 
et al. (1996) demonstrated this by giving a battery of cognitive tests to 70 male subjects 
between the ages of 54 and 81 years. As a result, lower levels of both vitamins correlated 
with a high concentration of homocysteine, which produced a poor memory response.
The higher levels of folate and B12 improved the outcomes of the cognitive exams on 
two measures of memory.
The correlation between elevated homocysteine levels and individuals with 
Alzheimer’s type dementia is not fully understood, however, scientist have reported that 
people with Alzheimer’s disease have no S-adenosylmethionine (SAMe) in their brains, 
which is required for maintenance and repair of the brain cells (Segala, 2001).
Summary
The discovery of homocysteine dates back to the 1933 with the death of a young 
boy with symptoms normally associated with older adults. It was not until the 1965 when 
the cause of death was determined to be homocysturinia. From the time of discovery 
until now, research involving homocysteine has been extensive and continues to expand.
Elevated homocysteine levels have become an important biochemical marker for 
coronary heart disease (CHD). Several studies (Stampfer et al., 1992; Selub et al., 1995; 
Malinow et al., 1995; Malinow et al., 1989; Berwanger et al., 1995) bave shown a strong
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correlation between elevated homocysteine levels and CHD, cerebrovascular disease, and 
peripheral arterial occlusive disease.
There are several factors leading to the causes of elevated homocysteine levels 
such as heredity, age, and gender. These factors are unalterable, there are some factors 
that are alterable such as diet and possibly exercise (Nygard et al., 1995; Malinow et al., 
1996; Genest et al., 1991; William et al., 1990). Elevated homocysteine is more common 
in those that demonstrate an inherited factor; as well elevated homocysteine is more 
common in older adults rather than younger adults. Homocysteine levels are commonly 
higher in men than in women. However, postmenopausal women tend to have higher 
levels than premenopausal women due to the related estrogen status.
Elevated homocysteine levels have been associated with increased levels of 
cholesterol and triglycerides (Karmin et al., 1998; Glueck et al., 1995). However, more 
research is needed in this area. Due to inconsistent results (Gerhard et al., 1999; Giles et 
al., 1999) research is needed to determine the relationship between homocysteine levels 
and ethnicity. Other areas of research related to elevated homocysteine levels include 
diabetes, kidney disease, and Alzheimer’s disease. These also show a correlation with 
elevated homocysteine levels.
Homocysteine has been widely researched and related heart disease. Both 
unalterable risk factors and alterable risk factors have been examined. However, more 
research is needed to determine the effect exercise has on homocysteine levels.
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CHAPTER 3 
METHODOLOGY
There are several unalterable factors in elevated serum homocysteine levels such 
as heredity, age, and gender. However, there are other factors that are or maybe 
alterable: these are diet and exercise. The purpose of the study was to determine if a 12- 
week progressive exercise program, which met five days a week for 45 minutes would 
significantly effect serum homocysteine levels in men and women.
Participants
Ten men and women between the ages of 32 and 50 years of age participated in 
the study. The female subjects were all premenopausal. Subject’s homocysteine levels 
were 10 umol/L or greater. The subjects were all sedentary, business or professional 
individuals who joined the study to improve their physical fitness.
Subject Selection
Homocysteine has been widely researched and related to heart disease. The 
University of Nevada, Las Vegas exercise physiology laboratory conducts an 
experimental exercise program, which studies the effect of daily exercise on the aging 
process and on coronary risk factors. This program has been conducted for the past 26 
years. The exercise program meets Monday through Friday for 45 minutes of exercise 
each day. The program is a formally lead, progressive exercise program consisting of
26
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flexibility and stretching exercises, strength and muscular endurance exercises, and 
cardio-respiratory exercises, (see Appendix A for exercise class details) In the fall of 
2001 all 22 of the new exercise participants were recruited to participate in the present 
study. In addition to the normal physical fitness test battery (see Appendix B for test 
battery) and the usual blood profile, all new participants were also tested for 
homocysteine levels. Of the 22 new participants 11 had homocysteine levels 10 umol/L 
or greater and these 11 were identified to be in the study. One subject whose 
homocysteine levels were extremely high was later eliminated as an outlier. The exercise 
program is a year-long program. However, for the present study the new participants 
were tested before and after 12 weeks. Previous results had shown that the major 
changes in physical fitness occurred during the first 12 weeks. Those who participated in 
the 12-week homocysteine study attended at least 75% of the exercise sessions. Table 1 
presents the subjects physical characteristics.
Table 1 Physical Characteristics of Subjects
Subjects Height (In) W eghtlO is) %Fat
MALES
1 70 177 26
2 74 225 36
3 70 177 26
4 69 170 23
5 70 180 26
6 73 185 29
Mean for males 71 186 28
FEMALES
7 53 125 28
8 52 120 32
9 51 118 29
10 53 175 38
Mean for females 52 135 32
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Pre-exercise Physical Fitness Assessment 
Prior to the exercise program starting, the participant’s physical fitness was 
assessed using a standard physical fitness test battery. The physical fitness test battery 
consisted of items to evaluate flexibility, strength and muscular endurance, cardio­
respiratory fitness, and body composition, (see appendix B for complete test battery) 
Participants were asked to not change their diets or physical activity levels and not to 
begin any diet supplementation, so that the only factor affecting any possible change in 
their homocystiene levels would be the daily exercise.
The Exercise Program 
After the physical fitness assessment was completed, the 12- week exercise 
program was started. Participants met Monday through Friday and participated in a 
progressive general exercise class. Attendance was taken daily. The class started at an 
intensity of approximately 35-50% of V02 max and increased intensity weekly so that at 
the end of the 12-week period, participants were working at an intensity of approximately 
85% of maximum oxygen uptake. The exercises stressed warm-up and stretching, 
muscular strength and endurance, cardio-respiratory exercises and a cool down period 
(See Appendix A for exercise class details).
Post-Experimental Period 
At the end of the 12 weeks of exercise all physical fitness tests were repeated and 
homocystiene levels were again determined.
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Homocysteine Determination
Homocysteine levels were determined at a local medical laboratory. Subjects 
were asked to report to the medical laboratory after a 14 hour fast during which no food 
or drink, other than a reasonable quantity of water for thirst. Subjects were asked not to 
exercise 12 hours before reporting to the laboratory and were asked to get at least 8 hours 
of sleep the previous night. Three 10ml syringes of blood were drawn from the 
antecubital vein. The blood was centrifuged and 10 cc were used to determine serum 
homocysteine. Homocysteine ultraquant was determined by a micro particle enzyme 
immunoassay procedure.
Statistical Analysis
The purpose of the study was to investigate the effects of a daily 12-week exercise 
program on homocysteine levels.
Ho: Exercise has no effect on Homocysteine levels.
HI: Exercise reduces Homocysteine levels.
A dependent one tailed t test was performed to evaluate the changes in mean 
homocysteine values, before and after the 12-week exercise program, (oc = .05)
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CHAPTER 4
RESULTS AND DISCUSSION 
The purpose of the present study was to investigate the effects of a 12-week 
exercise program on homocysteine levels in men and women. The research question was: 
Does regular exercise reduce homocysteine levels? Homocysteine levels were 
determined prior to the 12-week exercise program and again at the end of the 12-week 
period. The homocysteine levels were then evaluated for any significant changes.
Subjects
Subjects in the study were business or professional men and women ranging from 
32 to 50 years of age. All subjects were sedentary prior to the program and joined the 
program to improve their physical fimess level. All subjects attended at least 75% of the 
exercise sessions. Table 1 in chapter 3 presents the physical characteristics of the 
subjects prior to the 12 week exercise program beginning. The females had a mean 
weight of 128 lbs and a mean height of 64 inches. Their body composition was not 
unusual for the average female, namely 29.8% body fat. The males were likewise normal 
for the adult population with an average height and weight of 70.5 inches and 181 lbs.
The males’ percent body fat was 26.2%. The average attendance during the 12-weeks of 
exercise was 79.2%. During the physical fitness testing following the 12 weeks of 
exercise all tests items improved although weight and body composition did not
30
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change dramatically (see Appendix E for fitness test scores). Figure 2 and 3, and 4 
present the changes in body composition, strength, and cardio-respiratory fitness levels.
Body Composition Changes 
in Men
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Figure 2. Changes in Body Composition in Men and Women.
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Cardio-Respiratory Changes in Men
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Figure 4.Cardio-Respiratory Changes in Men and Women
Data Analysis
A dependent t test was performed to evaluate the changes in homocysteine levels 
following the exercise program (a = .05). The mean homocysteine level prior to the 
exercise program was 12.47 umol/L and the mean homocysteine level after the 12-week 
period was 11.18 umol/L. The mean difference was 1.29 from week 1 to week 12. Table 
2 shows the individual values and the mean values of homocysteine.
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Subject H cvTl HcyT2 dlff.T1&T2 %attendance
1 10.3 10.1 0.2 80
2 12.6 11 1.6 82
3 12.6 11 1.6 78
4 11.1 10 1.1 81
5 12.7 12.6 0.1 76
6 14.9 13.7 1.2 75
7 15.1 12.7 2.4 83
8 10.5 9.1 1.4 84
9 11.6 10.3 1.3 77
10 13.3 11.3 2 76
Total 124.7 111.8 12.9 792
Mean 12.47 11.18 1.29 79.2
Standard Deviation 1.66 1.43 .714
Standard Error 0.53 0.45 0.23
Due to his extremely high levels of homocysteine subject 11 was considered an outlier 
and was eliminated from the statistical analysis because he was not representative of the 
population.
Changes in Homocysteine (Hey)
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Figure 5. Illustrates the changes in homocysteine over 12 weeks.
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The analysis revealed a significant difference in homocysteine levels after the 12-week 
exercise program (t = 5.71, p<.05). The result of the statistical analysis provides 
evidence that regular exercise does reduce homocysteine levels in men and women.
Table 3 Paired T test for changes in homocysteine
t-Test: Paired Two Sample for Means
Variable 1 Variable 2
Mean 12.47 11.18
Observations 10 10
Hypothesized Mean 0
Difference
df 9
t Stat 5.712838
P(T<=t) one-tail 0.000145
t Critical one-tail 1.833114
Discussion
The present study revealed a statistically significant change in homocysteine 
levels after a 12-week exercise program. Six men and four women participated in the 
study to improve their physical fitness. It was assumed that all women were 
premenopausal based on the ages of the subjects ranged from 32 to 50 years of age. All 
subjects reported that they were free of any known heart disease or any other major 
medical condition. Subjects reported being sedentary prior to the exercise program and 
were asked to refrain fi-om changing their diet or to begin taking any supplements other 
than their multivitamin.
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The exercise program consisted of stretching, muscular strength and endurance, 
cardio-respiratory exercise and a cool down. Attendance was taken and subjects attended 
a minimum of 3 out of 5 days per week for the 12-week period.
A large volume of research has been published about homocysteine in the last 
decade; however, to date little research has been published on the specific effects of 
regular exercise and homocysteine levels. Nygard et al. (1995) showed a correlation 
between exercise and homocysteine levels in the Norwegian Hordaland Homocysteine 
study. However, Wright et al. (1998) showed that one bout of 30 minutes of acute 
exercise has no effect on homocysteine levels.
It is an accepted fact in the medical population that elevated cholesterol levels are 
a major risk factor for heart disease and that cholesterol can be lowered by regular 
exercise and diet. Normal levels of cholesterol should be below 200 for total cholesterol 
with LDL levels below 130 and HDL above 35. Exercise can increase HDL cholesterol 
and lower total cholesterol. But there is only limited information about the effect of 
regular exercise on serum homocysteine levels (Malinow et al., 1999; Spectra Cell Lab; 
Franklin, 1998; Stein et al. 1998; Boushley et al., 1995). The present study gives 
evidence that regular exercise lowered homocysteine levels.
Overall there was a 10% reduction in homocysteine levels over the 12 weeks and 
while this is statistically significant there is a question whether, from a practical 
preventive standpoint, this is a significant reduction. There is little research to indicate 
the magnitude of homocysteine reduction necessary to significantly reduce the risk of a 
cardiovascular accident. It is possible that exercise for a longer period of time might 
reduce homocysteine levels enough to show that homocysteine has been reduced enough
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to lessen the chance of cardiovascular disease. It would be especially important to 
determine if homocysteine levels gradually decline with training and at what point 
homocysteine has a plateau affect. However, even though the present study only showed 
a slight decline in homocysteine levels with exercise, the trend was toward lowering 
homocysteine levels. Perhaps, with the combination of exercise and diet, homocysteine 
levels may be reduced to lessen the incidence of coronary heart disease.
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SUMMARY, CONCLUSIONS AND RECOMMENDATIONS
Summary
Cardiovascular disease is the major cause of death in the United States. Elevated 
serum homocysteine is an accepted risk factor for coronary heart disease along with 
hypertension, uncontrolled diabetes, elevated cholesterol levels, cigarette smoking, lack 
of exercise, and obesity. Homocysteine was originally discovered in the 1933 and 
elevated levels were seen in children with mental retardation. However, research, which 
showed the relationship between elevated homocysteine levels and coronary heart 
disease, did not start imtil 1976 (Wilcken et al.,1976). Since then several studies have 
related elevated homocysteine levels with heart disease (Boushley et al., 1995, Malinow 
et al., 1994, Nygard et al., 1995, Stampfer et al., 1992, Kang et al., 1986, etc). Even 
though most medical diagnostic laboratories indicate homocysteine levels between 5 and 
15 umol/L to be a normal range, studies (Segala et al., 2000) have demonstrated that 
homocystiene levels above 6.3 umol/L cause a progressive risk of a heart attack.
It has also been determined that elevated homocysteine is a heritable factor 
(Malinow et al., 1996, Genest et al., 1991, Reed et al., 1991, Berg et al., 1992). Age, 
gender, menopause, elevated cholesterol, diabetes, kidney disease, and Alzheimer’s 
disease have also been linked to elevated homocysteine levels. However, little research 
has been completed showing the relationship between regular exercise and homocysteine
37
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levels. Total cholesterol and particular low-density lipoproteins, which are both, 
important in coronary heart disease, have been shown to be beneficially effected by 
regular exercise. This relationship sparks an interest as to whether exercise may also 
beneficially effect homocysteine levels.
The purpose of the current study was to determine whether a 12-week exercise 
program lowered homocysteine levels in men and women. Homocysteine levels were 
determined prior to the beginning of the 12-week period and again at the end of the 12 
weeks. Homocysteine levels were then assessed for changes. A dependent t test revealed 
a statistically significant decrease in homocysteine levels after the 12-week exercise 
program.
In order to lower the risk for heart disease it is important to eat a healthy diet in 
order to lower cholesterol levels and homocysteine levels and also supplement the diet 
with Vitamin B12, B6, and folic acid if needed. The results of the present study indicate 
that regular exercise also assists in lowering elevated homocysteine levels.
Conclusion
Twelve weeks of regular, progressive exercise for 45 minutes five days a week, 
produced a statistically significant reduction in serum homocysteine levels in 10 male and 
female subjects.
Recommendations for Further Research
1. It is recommended that a larger number of subjects be studied. Ten subjects were
examined in the current study and more subjects may change the results of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
39
study and would allow a better opportunity to make inferences about the general 
population.
2. It is recommended that subject’s diets be more carefully assessed and controlled. 
Subjects were asked not to change their diets during the experimental period and 
it was assumed that all subjects were compliant with the request. However, a 
daily diet record, and a record of supplement use would present evidence that it 
was not dietary change that effected the homocysteine levels.
3. It is recommended that prior to subject selection that a questionnaire be completed 
by all subjects to determine any use of medication, supplements, and vitamins, 
and to indicate the amount and kind of exercise they have participated in.
4. It is recommended that a longer exercise period be studied. Twelve weeks 
produces changes in physical fitness but blood variables may need prolonged 
activity to produce significant and meaningful changes.
5. It is recommended that different types of exercise programs be used. The present 
study used an overall general fitness regimen. It would be desirable to determine 
if changes occurred with a more intense aerobic training and/or with strictly 
anaerobic training such as strength training.
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Exercise Class Description
The University of Nevada, Las Vegas Adult Exercise Research Program 
is designed to improve the quality of lifestyle by providing a program 
of physical exercise prescribed on the basis of sound physiological and 
biomedical principles.
The program of exercise starts at a low level of intensity and 
progresses in intensity each w eek. Time is needed to adapt to the  
stress of regular exercise.
The class m eets as a group five days a w eek, Monday through Friday, 
beginning in Septem ber and continuing through August. The program  
has been m eeting for the past 27 years and 25 individuals have been  
in the program for 20 years or more. With new people starting each  
Septem ber there is now over a total of 100 people. New m em bers that 
start Septem ber are trained initially as a separate group from the  
other ongoing m em bers. Both groups (beginning and old) m eet at the  
sam e tim e, in the sam e facility, and share the sam e instructors, but 
are exercised separately. In February, the beginning group has 
progressed sufficiently to join the "on-going" class. The combined  
group then com pletes the year as one class. The following Septem ber  
the cycle starts again.
The Testing Program.
The program includes laboratory evaluations of physical fitness, body 
com position, blood pressure, heart rate, a com plete blood profile, and 
an electrocardiogram. A locker, exercise mat, surgical tubing, chinning 
bar and the daily exercise leadership are also provided. Medical 
clearance from the participant's personal physician is required prior to  
starting the program to determ ine whether or not there is any 
pathological reason why one should not participate in this exercise  
study. After receiving medical clearance and signing an informed 
consent form and a spouse agreem ent form, participants will be tested  
in the UNLV Exercise Physiology Laboratory, and a blood profile will be 
taken at a local medical facility.
Although the blood profile is an executive panel, it has an 
em phasis on the lipid items: i.e. HDL Cholesterol, LDL
41
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Cholesterol, Total Cholesterol, total/HDL ratio, triglycerides, 
apolipoprotein A-1, B and their ratio (an excellent biochemical marker 
of coronary heart d isease). Additional blood com ponents such as 
glucose, uric acid, electrolytes, blood enzym es and a com plete CBC are 
included. Physical fitness m easurem ents include cycle ergom eter test, 
maximum oxygen uptake, body type (som atotype) photograph, 
flexibility, strength, body composition (underwater weighing, 
bioim pedance, and skinfolds) and the heart's response to exercise.
All th ese  tests  are administered in Septem ber and in May during the  
first year, and then each May thereafter. From our data, the changes  
that occur from Septem ber to May dramatically show the beneficial 
effect of regular exercise on coronary risk factors and physical 
efficiency. The effect over tim e show s that regular exercise prevents 
the decline in fitness attributed to age.
The Exercise Program
The supervised exercise consists of four com ponents: 1) warm-up and 
stretching, 2) strength and muscular endurance, 3) cardiorespiratory 
or aerobic, and 4) cool-down.
The warm-up period includes 5-7  m inutes of flexibility exercises  
consisting of bending, stretching and twisting. These exercise are 
designed to stretch the m uscles while allowing the joints to go through 
their full range of m ovem ent. At the beginning of the year m ore tim e is 
spent in this phase than later. Emphasis is put on exercises for low 
back pain.
Exercises for muscular strength and endurance include calisthenics 
such as push-up, sit-ups, chest raising, chins etc. These exercises are 
designed to exercise each major m uscle group using the body's weight 
as resistance.
For the aerobic or cardiorespiratory portion of the class; the wom en  
bench step  and jog , and the men bench step  and swim . Swimming is 
not a prerequisite of the class since the university pool is divided into a 
25-yard deep pool and a 25-yard shallow pool. The beginning class 
d oes water walking.
The final part of the program is the cool-down period during which 
tim e the body returns to its resting pre-exercise level. These exercises  
are similar to the warm-up exercises, and are more important in the 
wom en's class as the heat generated by the exercise and jogging  
needs to be dissipated, w hereas the swimming tends to cool the body 
down in the pool.
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The Research
The exercise research program studies three main em phasis: 1) the  
longitudinal effect of daily, regular exercise on the factors that play a 
role in the developm ent of heart d isease. 2) the effect of short term  
exercise on selected  physiological variables; 3) the effect of regular 
exercise on the aging process.
It is not a program for individuals who have a history of 
heart d isease , major risk factors or are sym ptom atic. It is 
not a cardiac rehabilitation program. Attendance is taken 
each day and is an important com ponent of the study.
70% attendance (4 tim e a w eek) is requested although few busy 
professional people can attain that attendance. But regular attendance  
is encouraged since regular, progressive exercise is safe , w hereas 
sporadic, irregular exercise can be potentially dangerous. The 
experim ental and progressive period is from Septem ber to May. During 
the sum m er the program m eets four days a w eek and does not 
progress in intensity.
In addition to the above research, class m em bers are also able to  
participate in other research studies that the laboratory conducts. This 
is strictly voluntary. In the past th ese  studies have included the effect 
of exercise on body com position, weight loss, therm oregulation, diet 
and blood pressure, certain blood variable, etc.
The Benefits
Research evidence (both ours and others) has shown that participation 
in regular, vigorous exercise is extrem ely beneficial. In 1996 the  
Surgeon General of the United States released the Surgeon General's 
Report on Physical Activity and Health clearly sum m arizes th ese  
benefits. Physiological and psychological changes, which have been  
shown with routine exercise, include:
• D ecrease in resting and exercise heart rate
• D ecrease in arterial blood pressure
■ Increase in cardiac efficiency
■ Improved body com position (m ore m uscle and less fat)
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■ Reduction in total serum cholesterol and an increase in HDL 
cholesterol
(the good cholesterol)
■ Prevention of strength loss with age
■ Reducing, preventing or slowing down the physiological effects of 
aging
■ Improved self-im age
■ Improved se n se  of well-being  
• Reducing stress levels
Changes such as th ese , reduce the risk of coronary heart d isease  (the  
leading cause of death in men and w om en); provide greater sources of 
energy for work and leisure; and create a positive outlook toward life.
From Golding, Lawrence. (1992). Adult Exercise Research Program-Handbook. 
Unpublished participants handbook. University of Nevada, Las Vegas.
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UNIVERSITY OF NEVADA, LAS VEGAS 
Adult E x e rc ise  P rog ram s-S co re  S h e e t
Be s u re  to  fill in a ll s p a c e s
Subject’s  Name:_____________
Name of Tester:_____________
I D. Number:
Date: / I
Age (yrs. day of test): _  Birthdate:_
month day year 
. Attendance (%):__
1. Resting Heart Rate (bpm):. 2. Resting B.P. (mmhg):___l_
3. Weight (lbs):_ 4. Height (ins):_ 5. EKG: YES/NO
6. Skinfolds (mm) (Done by:___) Caliper used circle: Lange I Harpenden
, Check off .
Chest: ______ mm Triceps:_____ mm
Abdomen:
Hip:
Side:
mm Back: mm
mm Thigh: mm
mm Waist Girth: cm
7. Step Test (post-exercise 1 min. HR): beats
8. Flexibility 2 triais-(ins.-circie best): ins ins
9. Grip Strength (circle R or L): R L  kg
10. Bench (reps):
11. Bike Test:
Curls (reps): Crunches (1 min):
1.
2 .
3.
4.
5.
6 .
7.
8 .
9.
10. 
11. 
12.
13.
14.
Seat height:
1st W k.Ld;____________ kgm HR: 2'"’Min._____ 3"'min._____4“’ min_
12nd Wk.Ld: 
j  3rd Wk Ld: kam  H R :2 '“ Min._
J  4th Wk.Ld: kam  HR: 2""Min.
_3"*min._
3"*min.
NOTE: Check boxes for workloads & heart rate to be used.
12. Photo (circle): Yes / No 13. Blood Appointment: Yes / No
(no shoes or socks) (Give blood order form if not received!
14.CHECK N O W - A R E  ALL SPACES FILLED IN?
PUT IN COMPUTER? YES/NO 
COMPLETE? YES/NO
P rin ted  ou t: YES NO 
M ailed: YES/NO
From Golding, Lawrence. (1992). Adult Exercise Research Program-Handbook. 
Unpublished Participants handbook. University of Nevada, Las Vegas.
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Informed Consent
I, Tracey ZuehlsdorfF am a graduate student in the Exercise Physiology 
department at the University of Nevada, Las Vegas. As a graduate student I am working 
on my thesis and conducting a research project to determine the effects of a 12-week 
training program on homocysteine levels in men and women. I invite you to participate 
and act as a subject in this research project. The study is 12 weeks in length and prior to 
the training program, hlood tests will be done to determine homocysteine levels. Those 
with homocysteine levels above 10 umol/L will undergo a 12-week aerobic type exercise 
program at least three times a week. At the end of the 12 weeks, homocysteine levels 
will be evaluated again.
There are many benefits to participating. First, your involvement will help 
discover the effects that exercise have on homocystiene levels, a new risk factor for heart 
disease. As well, there are many personal benefits to exercise such as weight loss, 
reducing cholesterol, controlling hypertension, and fighting other risk factors for heart 
disease. There is no cost to you as a subject and all information concerning you is 
confidential and will be in file locked in a cabinet in Dr. Larry Golding’s office.
If you have any questions concerning the project please contact myself, Tracey 
Zuehlsdorff at 437 -  8745 or Dr. Larry Golding (SIRC 100) at 895 -  3766. For any 
questions about the rights of research subjects, contact the Office for the Protection of 
Research Subjects at 895 -  2794.
Participation in this study is voluntary and one may withdraw at any time during 
the study; however, your full participation is greatly appreciated.
I wish to participate Date
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Raw Data
Subject hoy wk 1 hoy wk 12 difference
1 10.3 10.1 0.2
2 12.6 11 1.6
3 12.6 11 1.6
4 11.1 10 1.1
5 12.7 12.6 0.1
6 14.9 13.7 1.2
7 15.1 12.7 2.4
8 10.5 9.1 1.4
9 11.6 10.3 1.3
10 13.3 11.3 2
Mean 12.47 11.18 1.29
SD 1.660689 1.430462 0.714065
Std error 0.525156 0.452352 0.225807
t-Test: Paired Two Sample for Means
Variable 1 Variable 2
Mean 12.47 11.18
Observations 10 10
Hypothesized Mean Dr 0
df 9
t Stat 5.712838
P(T<=t) one-tail 0.000145
t Critical one-tail 1.833114
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Changes in Body Composition
Subject Wt (lbs) % Fat Ht(in)
Wki Wk12 Wki Wk12 Wki Wk12
Males
1 177 175 26 25 70 70
2 225 210 36 30 74 74
3 177 175 26 26 70 70
4 170 170 23 22 69 69
5 180 175 26 25 70 70
6 185 180 29 25 73 73
Mean 186 181 28 25 71 71
Females
7 125 120 28 23 53 53
8 120 120 32 26 52 52
9 118 120 29 25 51 51
10 175 170 38 31 53 53
Mean 134 132 32 26 52 52
Total avg 165 161 29 26 63 63
Changes in Strength
Subject Bench* Curls* SitUps* Grip*
Wki Wk12 Wki Wk12 Wki Wk12 Wki Wk12
Males
1 12 16 13 15 30 38 30 42
2 10 15 9 16 25 33 28 40
3 10 15 11 12 33 40 36 42
4 14 16 10 16 36 15 30 41
5 9 15 11 15 30 36 29 38
6 9 16 11 11 25 32 28 40
Mean 11 15 11 14 30 32 30 40
Females
7 10 15 10 13 30 38 32 41
8 12 17 9 15 32 41 32 45
9 13 14 10 15 28 32 30 40
10 3 6 6 10 16 26 25 36
Mean 9 13 9 13 26 34 30 40.0
Total avg 10 14 10 14 28 33 30 40
‘ Note; Bench, Curls, and Sit Ups are m easured in repetitions and Grip 
Strength is m easured in Kg.
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Cardiovascular Fitness Changes
Subjects RHR BP-S/D PWC(kg V02(ml/kg) Step Test
Wki Wk12 Wki Wk12 Wki Wk12 Wki Wk12 Wki Wk12
Maies
1 81 72 130/90 125/85 1000 1400 33 36 129 109
2 83 71 120/95 120/85 900 1200 26 32 136 110
3 88 73 135/85 130/80 1100 1250 34 35 123 112
4 77 69 130/80 130/80 900 1150 30 33 116 108
5 76 68 145/90 130/90 850 1200 26 32 125 110
6 81 72 155/95 145/85 950 1350 30 36 132 116
Mean 81 71 136/89 132/84 950 1258 30 34 127 111
Females
7 84 70 130/85 125/80 980 1250 29 32 136 110
8 83 71 135/90 130/85 800 1100 26 31 140 121
9 81 72 140/80 130/75 950 1250 25 28 136 119
10 86 81 145/90 140/80 800 1100 21 30 152 135
Mean 83 73 137/86 131/80 882 1175 25 30 141 121
Total avg 82 71 136/88 130/82 928 1228 28 32 132 115
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